• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC 5.15% $1.43

RACE ONCOLOGY LTD

Race Oncology Limited is an Australia-based clinical-stage biopharmaceutical company. The... Race Oncology Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on improving the lives of cancer patients around the world by developing a novel approach to both treating the cancer and protecting the heart. Its lead asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a clinical history with demonstrated therapeutic benefits in both adult and pediatric patients, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. It is advancing a reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations. It is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia.More

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
2019 SP
2
28/03/19 63 17K
28/03/19 Last post  EWexplorer Comments Created with Sketch.  63  Views Created with Sketch.  17K 
RAC 26/03/19 7 1.3K
26/03/19 Last post  Hillyhawkie Comments Created with Sketch.  7  Views Created with Sketch.  1.3K 
RAC
RAC (ASX) Corporate Spotlight Updates
25/03/19 3 783
25/03/19 Last post  Corporate Spotlight Comments Created with Sketch.  3  Views Created with Sketch.  783 
RAC 13/03/19 1 560
13/03/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  560 
RAC 27/02/19 1 456
27/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  456 
RAC 25/02/19 4 1.5K
25/02/19 Last post  EWexplorer Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
RAC 14/02/19 0 277
14/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  277 
RAC 12/02/19 1 567
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  567 
RAC 12/02/19 1 514
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  514 
RAC 12/02/19 0 238
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  238 
RAC 12/02/19 0 201
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  201 
RAC 08/02/19 3 976
08/02/19 Last post  EddyG Comments Created with Sketch.  3  Views Created with Sketch.  976 
RAC 31/01/19 2 3.1K
31/01/19 Last post  Infidel75 Comments Created with Sketch.  2  Views Created with Sketch.  3.1K 
RAC 23/01/19 13 3.1K
23/01/19 Last post  mcexplorer Comments Created with Sketch.  13  Views Created with Sketch.  3.1K 
RAC 09:49 0 282
09:49 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  282 
RAC
5 Million Shares bought by Insider
15/01/19 21 7.0K
15/01/19 Last post  mcexplorer Comments Created with Sketch.  21  Views Created with Sketch.  7.0K 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
$1.43
Change
0.070(5.15%)
Mkt cap ! $282.0M
Open High Low Value Volume
$1.42 $1.44 $1.39 $158.3K 112.3K

Buyers (Bids)

No. Vol. Price($)
1 20596 $1.40
 

Sellers (Offers)

Price($) Vol. No.
$1.44 2000 1
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$1.42
  Change
0.070 ( 3.66 %)
Open High Low Volume
$1.44 $1.44 $1.40 7627
Last updated 15.59pm 21/11/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.